U.S. markets open in 7 hours 31 minutes

FDA clears new version of Abbott's diabetes glucose monitor

Abbott announced on Monday the FDA approved its FreeStyle Libre 2 integrated continuous glucose monitoring system for adults and children with diabetes. Abbott's Senior Vice President Diabetes Care Jared Watkin joins Yahoo Finance’s On The Move panel to discuss.